ReviewBMJ global health2018
Banking for health: the role of financial sector actors in investing in global health.
Review in BMJ global health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Integrating ESG indicators into public health governance as a policy innovation for institutional accountability: a scoping review.Public health reviews · 2026Review
- Mobilizing the banking sector for universal health coverage: a new frontier for public-private partnerships.Frontiers in health services · 2026Article
- Can technology be good for health? Investigating health-promoting strategies in the private sector.Frontiers in public health · 2024Article
- Journey from an Enabler to a Strategic Leader: Integration of the Medical Affairs Function in ESG Initiatives and Values.Pharmaceutical medicine · 2023Article
- Unfinished business: Lessons for future G20 meetings on a more inclusive understanding of universal health coverage.GHM open · 2022Review
- The healthcare inequality among middle-aged and older adults in China: a comparative analysis between the full samples and the homogeneous population.Health economics review · 2022Article
- A 'whole of United Nations approach' to tackle antimicrobial resistance? A mapping of the mandate and activities of international organisations.BMJ global health · 2022Review
- Re-Examining the Financial Structure and Health Nexus in Asian Economies.Frontiers in public health · 2022Article
- Considerations for diagnostic COVID-19 tests.Nature reviews. Microbiology · 2021Review
- Real-Life Incentives Driving Public-Private Partnership in Diagnostic Services.Ethiopian journal of health sciences · 2020Article
- Healthcare Transformation in the Post-Coronavirus Pandemic Era.Frontiers in medicine · 2020Article
- Finance, data and technology initiatives for noncommunicable disease control.Bulletin of the World Health Organization · 2019Article
- Sustainable development for global mental health: a typology and systematic evidence mapping of external actors in low-income and middle-income countries.BMJ global health · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The world faces multiple health financing challenges as the global health burden evolves. Countries have set an ambitious health policy agenda for the next 15 years with prioritisation of universal health coverage under the Sustainable Development Goals. The scale of investment needed for equitable access to health services means global health is one of the key economic opportunities for decades to come. New financing partnerships with the private sector are vital. The aim of this study is to unlock additional financing sources, acknowledging the imperative to link financial returns to the providers of capital, and create profitable, sustainable financing structures. This paper outlines the global health investment opportunity exploring intersections of financial and health sector interests, and the role investment in health can play in economic development. Considering increasing demand for impact investments, the paper explores responsible financing initiatives and expansion of the global movement for sustainable capital markets. Adding an explicit health component (H) to the Environmental, Social and Governance (ESG) investment criteria, creating the ESG+H initiative, could serve as catalyst for the inclusion of health criteria into mainstream financial actors' business practices and investment objectives. The conclusion finds that health considerations directly impact profitability of the firm and therefore should be incorporated into financial analysis. Positive assessment of health impact, at a broad societal or environmental level, as well as for a firm's employees can become a value enhancing competitive advantage. An ESG+H framework could incorporate this into mainstream financial decision-making and into scalable investment products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.